...
机译:淋巴式分析朝鲜人群中弥漫性大B细胞淋巴瘤的原始细胞分类及其与免疫组化算法的相关性
Department of Pathology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Pathology University of Ulsan College of Medicine Asan Medical Center;
Department of Otorhinolaryngology University of Ulsan College of Medicine Asan Medical Center;
Department of Pathology Samsung Medical Center Sungkyunkwan University School of Medicine;
Division of Hematology and Oncology Department of Medicine Samsung Medical Center Sungkyunkwan;
Division of Hematology and Oncology Department of Medicine Samsung Medical Center Sungkyunkwan;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Pathology University of Ulsan College of Medicine Asan Medical Center;
Diffuse large B cell lymphoma; Cell-of-origin classification; Asians; Lymph2Cx assay; Immunohistochemistry;
机译:淋巴式分析朝鲜人群中弥漫性大B细胞淋巴瘤的原始细胞分类及其与免疫组化算法的相关性
机译:基于免疫组织化学标准的弥漫性大型B细胞淋巴瘤患者的免疫组织化学标准和淋巴淋巴结分类的临床影响:一个中心经验和文学审查
机译:利用淋巴细胞测定评估HIV相关弥漫性大B细胞淋巴瘤的原产地亚型
机译:基因表达分析弥漫性大B细胞淋巴瘤的分类和生存预测
机译:FGFR-2(BEK)在弥漫性大B细胞淋巴瘤中的表达与临床相关性。
机译:通过Lymph2Cx分析确定弥漫性大B细胞淋巴瘤的起源细胞:比Hans算法更好的预后指标
机译:在BCL2和Myc表达状态的背景下,使用淋巴管测定弥漫大型B细胞淋巴瘤的原因分类